Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | HTT | P42858 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.41 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.41 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4201215 | 0.84 | SMN1; SMN2 (0.48) | SMN1; SMN2ALDH1A1HPGDMAPTHTT | |
| SCHEMBL6061975 | 0.78 | SMN1; SMN2 (0.67) | SMN1; SMN2ALDH1A1HPGDPOLBMAPT | |
| SCHEMBL1544495 | 0.72 | SMN1; SMN2 (0.58) | SMN1; SMN2ALDH1A1HPGDPOLBMAPT | |
| SCHEMBL13832085 | 0.69 | SMN1; SMN2 (0.67) | SMN1; SMN2ALDH1A1MAPTHTTGAA | |
| SCHEMBL2945422 | 0.69 | ALDH1A1 (0.73) | SMN1; SMN2ALDH1A1POLBMAPTGAA | |
| SCHEMBL12797796 | 0.69 | NPC1 (0.65) | SMN1; SMN2ALDH1A1HPGDPOLBMAPT | |
| SCHEMBL4202749 | 0.69 | SMN1; SMN2 (0.64) | SMN1; SMN2ALDH1A1HPGDPOLBMAPT | |
| SCHEMBL13832260 | 0.67 | SMN1; SMN2 (0.71) | SMN1; SMN2ALDH1A1HPGDPOLBMAPT | |
| SCHEMBL17159778 | 0.67 | HSD11B1 (0.54) | SMN1; SMN2ALDH1A1HPGDGAALMNA | |
| SCHEMBL4206719 | 0.67 | SMN1; SMN2 (0.64) | SMN1; SMN2ALDH1A1HPGDMAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060111348-A1 | Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders | NOVO NORDISK A/S (DK) | 2006-05-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060111348-A1 | Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders | HSD11B1, HSD11B2, HSD17B1 | SMN1; SMN2 3473/4885ALDH1A1 74/4885HPGD 84/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.